2 products were found matching "168273-06-1"!

No results were found for the filter!
Rimonabant
Rimonabant

Item number: TGM-T1519L-100mg

Description: Rimonabant (SR141716) is an inverse agonist for the cannabinoid receptor CB1. It is an anorectic anti-obesity drug produced and marketed by Sanofi-Aventis. Its main avenue of effect is a reduction in appetite. Rimonabant is the first selective CB1 receptor blocker to be approved for use anywhere in the...
Keywords: SR141716
Application: Targets cannabinoid receptor 1 (CNR1)
CAS 168273-06-1
MW: 463.79 D
From 42.00€ *
Review
Rimonabant
Rimonabant

Item number: Cay9000484-10

Rimonabant is a cannabinoid 1 (CB1) receptor antagonist (Ki = 5.6 nM). It is selective for CB1 over CB2 receptors (Ki = >1,000 nM), as well as a panel of 37 other receptors and channels (IC50s = >1,000 nM). Rimonabant (10 µM) inhibits phytohemagglutinin-induced proliferation of isolated human peripheral blood...
Keywords: SR141716, 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-1-piperidinyl-1H-pyrazole-3-carboxamide
Application: CB1 receptor inverse agonist
CAS 168273-06-1
MW: 463.8 D
From 63.00€ *
Review